When Mylan Pharmaceuticals increased the price of EpiPens by 400%, it sparked national outrage. But when medical instrument manufacturers increase prices for products that haven’t been changed in decades, hospitals and surgery centers are silent, choosing to be complacent and pay more instead of looking out for their best interests.